These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 24306088)

  • 41. Combined therapy with Fludarabine and cyclophosphamide in relapsed/resistant patients with B-cell chronic lymphocytic leukaemia and non-Hodgkin's lymphomas.
    Zaja F; Rogato A; Russo D; Marin L; Silvestri F; Baccarani M
    Eur J Haematol; 1997 Nov; 59(5):327-8. PubMed ID: 9414645
    [No Abstract]   [Full Text] [Related]  

  • 42. Health-related quality of life in younger patients with chronic lymphocytic leukemia treated with fludarabine plus cyclophosphamide or fludarabine alone for first-line therapy: a study by the German CLL Study Group.
    Eichhorst BF; Busch R; Obwandner T; Kuhn-Hallek I; Herschbach P; Hallek M;
    J Clin Oncol; 2007 May; 25(13):1722-31. PubMed ID: 17389338
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of therapy-related myeloid neoplasia after initial therapy for chronic lymphocytic leukemia with fludarabine-cyclophosphamide versus fludarabine: long-term follow-up of US Intergroup Study E2997.
    Smith MR; Neuberg D; Flinn IW; Grever MR; Lazarus HM; Rowe JM; Dewald G; Bennett JM; Paietta EM; Byrd JC; Hussein MA; Appelbaum FR; Larson RA; Litzow MR; Tallman MS
    Blood; 2011 Sep; 118(13):3525-7. PubMed ID: 21803850
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Population pharmacokinetics of rituximab in patients with chronic lymphocytic leukemia.
    Li J; Zhi J; Wenger M; Valente N; Dmoszynska A; Robak T; Mangat R; Joshi A; Visich J
    J Clin Pharmacol; 2012 Dec; 52(12):1918-26. PubMed ID: 22235140
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Altered treatment of chronic lymphocytic leukemia in Germany during the last decade.
    Zoellner AK; Höhler T; Fries S; Böhme A; Kiewe P; Kellermann L; Dreyling M
    Ann Hematol; 2016 May; 95(6):853-61. PubMed ID: 27021305
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706.
    Hussein MA; Gundacker H; Head DR; Elias L; Foon KA; Boldt DH; Dobin SM; Dakhil SR; Budd GT; Appelbaum FR
    Leukemia; 2005 Nov; 19(11):1880-6. PubMed ID: 16193091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pure erythroid leukemia evolving from a therapy-related myelodysplastic syndrome secondary to treatment for chronic lymphocytic leukemia.
    Sadrzadeh H; Hasserjian R; Fathi AT
    Am J Hematol; 2013 Mar; 88(3):240-1. PubMed ID: 22565525
    [No Abstract]   [Full Text] [Related]  

  • 48. Low-dose oral fludarabine plus cyclophosphamide in elderly patients with untreated and relapsed or refractory chronic lymphocytic Leukaemia.
    Forconi F; Fabbri A; Lenoci M; Sozzi E; Gozzetti A; Tassi M; Raspadori D; Lauria F
    Hematol Oncol; 2008 Dec; 26(4):247-51. PubMed ID: 18642397
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Long-term follow-up of 415 patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC trials: A comprehensive assessment of prognostic factors.
    Allsup DJ; Craig Z; Cairns D; Howard D; Hockaday A; Bloor A; Soe Z; Pepper C; Gattei V; Zucchetto A; Robbe P; Clifford R; Schuh A; Munir T; Rawstron A; Hillmen P
    Am J Hematol; 2022 May; 97(5):E168-E171. PubMed ID: 35108412
    [No Abstract]   [Full Text] [Related]  

  • 50. Cyclophosphamide for CLL: to be or not CYP2B activated?
    Geisler CH
    Blood; 2013 Dec; 122(26):4156-7. PubMed ID: 24357708
    [No Abstract]   [Full Text] [Related]  

  • 51. COSMIC, chemotherapy plus ofatumumab at standard or mega-dose in chronic lymphocytic leukaemia, a phase II randomised study.
    Allsup D; Howard D; Emmerson J; Hockaday A; Rawstron A; Oughton JB; Bloor A; Phillips D; Nathwani A; Paneesha S; Turner D; Munir T; Hillmen P
    Br J Haematol; 2021 Aug; 194(3):646-650. PubMed ID: 34028800
    [No Abstract]   [Full Text] [Related]  

  • 52. Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy.
    Coso D; Costello R; Cohen-Valensi R; Sainty D; Nezri M; Gastaut JA; Bouabdallah R
    Ann Oncol; 1999 Mar; 10(3):362-3. PubMed ID: 10355587
    [No Abstract]   [Full Text] [Related]  

  • 53. Fludarabine in chronic lymphocytic leukemia and other hematological malignancies: progress in treatment. Fludarabine supplement.
    Binet JL
    Hematol J; 2004; 5 Suppl 1():S1. PubMed ID: 15079147
    [No Abstract]   [Full Text] [Related]  

  • 54. Effects of rapamycin in combination with fludarabine on primary chronic lymphocytic leukemia cells.
    Rodriguez CM; Bussi C; Arroyo DS; Sastre D; Heller V; Stanganelli C; Slavutsky I; Iribarren P
    Leuk Lymphoma; 2019 May; 60(5):1299-1303. PubMed ID: 30407097
    [No Abstract]   [Full Text] [Related]  

  • 55. Cytotoxic combination of loxoribine with fludarabine and mafosfamide on freshly isolated B-chronic lymphocytic leukemia cells.
    Pellacani A; Tosi P; Zinzani PL; Ottaviani E; Albertini P; Magagnoli M; Tura S
    Leuk Lymphoma; 1999 Mar; 33(1-2):147-53. PubMed ID: 10194132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An atypical case of bilateral posterior scleritis in a patient with chronic lymphocytic leukemia.
    Soon AK; Chan TY
    Can J Ophthalmol; 2015 Aug; 50(4):e60-3. PubMed ID: 26257236
    [No Abstract]   [Full Text] [Related]  

  • 57. A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients.
    Tedeschi A; Rossi D; Motta M; Quaresmini G; Rossi M; Coscia M; Anastasia A; Rossini F; Cortelezzi A; Nador G; Scarfò L; Cairoli R; Frustaci AM; Dalceggio D; Picardi P; De Paoli L; Orlandi E; Rambaldi A; Massaia M; Gaidano G; Montillo M;
    Haematologica; 2015 Dec; 100(12):e501-4. PubMed ID: 26294723
    [No Abstract]   [Full Text] [Related]  

  • 58. High serum levels of CD178 (soluble FasL) predict for inferior progression free survival in chronic lymphocytic leukemia treated with fludarabine-based chemotherapy.
    Tate C; Burgess M; McMillan NA; Saunders NA; Cheung C; Gill D; Mollee P
    Leuk Lymphoma; 2019 Oct; 60(10):2563-2567. PubMed ID: 31237178
    [No Abstract]   [Full Text] [Related]  

  • 59. All is not lost--the improving outcome of patients with chronic lymphocytic leukaemia failing frontline therapy with fludarabine, cyclophosphamide and rituximab.
    Cheah CY; Lew TE; Lee R; Tam CS; Seymour JF; Carney DA
    Eur J Haematol; 2013 Aug; 91(2):189-90. PubMed ID: 23668259
    [No Abstract]   [Full Text] [Related]  

  • 60. Haemophagocytic lymphohistiocytosis following fludarabine/cyclophosphamide chemotherapy for chronic lymphocytic leukaemia.
    Jayakody Arachchillage D; Hurst E; Carey P; Moses S; O'Brien SG; Menne T; Keenan F; Wallis JP
    Br J Haematol; 2014 Jul; 166(1):142-5. PubMed ID: 24628491
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.